Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McKesson "Overpaid" For HBO, CEO Says; Revenues Revised Down $246 Mil.

Executive Summary

McKessonHBOC has revised its revenues down by $245.8 mil. for fiscal 1999 as a result of improper accounting by HBO & Company, which McKesson acquired in January.

You may also be interested in...



McKesson Sees Cash Flow Upside To Slow Growth, Inventory Management

McKesson sees a bright spot from the overall slowdown in the pharmaceutical market and the prevalence of inventory management arrangements: enhanced cash flow

McKesson Sees Cash Flow Upside To Slow Growth, Inventory Management

McKesson sees a bright spot from the overall slowdown in the pharmaceutical market and the prevalence of inventory management arrangements: enhanced cash flow

McKesson/Quintiles Info Services Venture Has Access To 40% Of U.S. Rxs

The McKesson/Quintiles information services joint venture will have access to up to 40% of prescriptions, plus 20% of medical claims in the U.S

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034515

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel